Jingjin Gao
About Jingjin Gao
Jingjin Gao is a Principal Scientist at Bristol Myers Squibb with extensive experience in clinical biomarker operations and translational medicine.
Current Role at Bristol Myers Squibb
Jingjin Gao currently serves as a Principal Scientist at Bristol Myers Squibb, working remotely from the San Francisco Bay Area. In this role, Jingjin applies expertise in translational medicine, focusing on the development and validation of novel diagnostic products under GCP guidelines. Jingjin supports various phases 1 and 2 clinical programs in cancer immunology and cell therapy.
Previous Role at Turning Point Therapeutics
From 2021 to 2023, Jingjin Gao worked at Turning Point Therapeutics in San Diego, California, serving as the Clinical Biomarker Operations and CDx Manager in the Translational Medicine department. In this capacity, Jingjin oversaw clinical biomarker operations and managed CROs, vendors, and central labs, leveraging over 5 years of experience in this field.
Career at Pfizer
Jingjin Gao has had two significant tenures at Pfizer. From 2015 to 2021, Jingjin was a Senior Scientist in Oncology Translational Research based in San Diego, California. Earlier, from 1997 to 2002, Jingjin worked as an Associate Scientist in La Jolla. During these periods, Jingjin supported multiple clinical programs and developed diagnostic products, adhering to FDA regulations, GxP, and QSR guidelines.
Experience at Johnson & Johnson
Between 2002 and 2014, Jingjin Gao was employed by Johnson & Johnson as a Senior Associate Scientist in San Diego, California. This extensive 12-year tenure involved contributing to various scientific projects, developing expertise in pharmaceutical research and diagnostics.
Educational Background
Jingjin Gao holds a Master of Science in Biotechnology and Genetics from Tsinghua University. Additionally, Jingjin earned a Master of Science in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill, and a Bachelor of Science in Biology/Biological Sciences from Peking University. This robust academic foundation underpins Jingjin's extensive career in scientific research and translational medicine.